• 点赞
  • 1
  • 收藏

Synthetic Biologics Sets 1-for-10 Reverse Stock Split

Dow Jones2022-07-15

 

By Will Feuer

 

Synthetic Biologics Inc. said it has set a 1-for-10 reverse stock split to ensure that the company can meet the per-share price requirements to remain listed on the NYSE American.

The stock will begin trading on a split-adjusted basis on July 25, the company said. The reverse stock split was authorized by the company's board on July 11. The number of outstanding common shares would be reduced to 15.8 million shares from 158.4 million shares.

The stock fell nearly 14%, to 20 cents a share, in premarket trading after the announcement.

 

Write to Will Feuer at Will.Feuer@wsj.com

 

$(END)$ Dow Jones Newswires

July 15, 2022 08:22 ET (12:22 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论1

  • Hbwen
    ·2022-07-15
    这是…
    回复
    举报
 
 
 
 

热议股票

 
 
 
 
 

7x24